Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Prospective Molecular Profiling of Circulating Tumor Cells from Patients with Melanoma Receiving Combinatorial Immunotherapy.
Journal: Clinical chemistry
Published: May 21, 2019
Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-κB Pathway in Melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 16, 2017
Correction: Ono, S.; Lam, S.; Nagahara, M.; Hoon, D.S.B. Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays. J. Clin. Med. 2015, 4, 1890-1907.
Journal: Journal of clinical medicine
Published: August 31, 2016
Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays.
Journal: Journal of clinical medicine
Published: July 07, 2015
A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients.
Journal: Oncotarget
Published: January 06, 2015
RASAL2 activates RAC1 to promote triple-negative breast cancer progression.
Journal: The Journal of clinical investigation
Published: April 21, 2014
Circulating tumor cells as prognostic biomarkers in cutaneous melanoma patients.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: November 22, 2013
Showing 1-7 of 7
Last Updated: 09/26/2026